Get started
Author

Barbara Weitmayr

Observed name: B. Weitmayr
OpenAlex ID: A5019077002
Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States
2023 · Lukas Janker, Dina Schuster, et al. · Journal of Crohn s and Colitis · 27
Salivary ghost cell carcinoma: case report and proposal of a new entity
2019 · Stephan Ihrler, Martin Mollenhauer, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 12
Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
2021 · Gregor Ortmayr, Laura Brunnthaler, et al. · Hepatology Communications · 11
Multi-omics empowered deep phenotyping of ulcerative colitis
2022 · Lukas Janker, Dina Schuster, et al. · medRxiv · 1
PDF
Response to the commentary of Ide et al. “ghost/shadow cell differentiation in salivary gland tumors”
2020 · Stephan Ihrler, Martin Mollenhauer, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1
PDF
5-FU based chemotherapy with bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor.
2016 · Birgit Gruenberger, Patrick Starlinger, et al. · Journal of Clinical Oncology · 1
Response to Induction Chemotherapy with Antibodies on the Primary Tumor and the Liver Metastases in Synchronous Metastastic CRC Patients
2021 · R. Lutz, P. Jonas, et al. · HPB
PDF
P-161 5-FU based chemotherapy with Bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor
2016 · B. Gruenberger, P. Starlinger, et al. · Annals of Oncology
PDF
Works count: 8
Citation count: 53
H-index: 3
I10-index: 3
Year
Topic
Type